The consensus on the diagnosis and treatment of elderly myelodysplastic neoplasm in China (2024)

Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid tumours originating from haematopoietic stem/progenitor cells, with a high prevalence in the elderly. Epidemiological surveys in Europe and the United States have revealed that the incidence of MDS is (4-5)/100 000, which increases...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Zhenduanxue lilun yu shijian
المؤلف الرئيسي:	MDS Professional Committee of Hematology Branch of Chinese Geriatrics Society
التنسيق:	مقال
اللغة:	الصينية
منشور في:	Editorial Office of Journal of Diagnostics Concepts & Practice 2024-06-01
الموضوعات:	\|geriatrics\|myelodysplastic syndrome\|myelodysplastic neoplasm\|diagnosis\|treatment
الوصول للمادة أونلاين:	https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1724233502606-46486499.pdf

مواد مشابهة

The immunobiology of myelodysplastic neoplasms: a mini-review
حسب: Shruthi Kannan, وآخرون
منشور في: (2024-09-01)

Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape
حسب: Daniel Karel, وآخرون
منشور في: (2024-04-01)

A Brief Overview of the Molecular Landscape of Myelodysplastic Neoplasms
حسب: Rami Abdulbaki, وآخرون
منشور في: (2024-04-01)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
حسب: Ziqi Wan, وآخرون
منشور في: (2020-10-01)

Immunophenotyping myelodysplastic neoplasms: the role of flow cytometry in the molecular classification era
حسب: Evgenia Verigou, وآخرون
منشور في: (2024-10-01)

Myelodysplastic Neoplasms (MDS): Pathogenesis and Therapeutic Prospects
حسب: Xuefeng Li, وآخرون
منشور في: (2025-05-01)

Flow cytometry in the differential diagnosis of myelodysplastic neoplasm with low blasts and cytopenia of other causes
حسب: Márk Plander, وآخرون
منشور في: (2024-07-01)

Molecular Drivers of Myelodysplastic Neoplasms (MDS)—Classification and Prognostic Relevance
حسب: Fieke W. Hoff, وآخرون
منشور في: (2023-02-01)

Efficacy of ruxolitinib in a patient with myelodysplastic/myeloproliferative neoplasm unclassifiable and co-mutated JAK2, SF3B1 and TP53
حسب: Qian Wang, وآخرون
منشور في: (2020-01-01)

How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
حسب: Carmelo Gurnari, وآخرون
منشور في: (2022-12-01)

Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasms
حسب: Esther Natalie Oliva, وآخرون
منشور في: (2025-02-01)

The myelodysplastic syndromes: diagnosis, prognosis and therapy
حسب: Cristina Clissa, وآخرون
منشور في: (2013-03-01)

The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms
حسب: Luca L. G. Janssen, وآخرون
منشور في: (2024-07-01)

IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
حسب: Rosangela Invernizzi, وآخرون
منشور في: (2015-04-01)

NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
حسب: Francesco D'Alò, وآخرون
منشور في: (2010-08-01)

NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
حسب: Mariangela Greco, وآخرون
منشور في: (2010-05-01)

Emerging Therapies for the Myelodysplastic Syndromes
حسب: Jonathan Canaani
منشور في: (2019-12-01)

Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms
حسب: Chantana Polprasert, وآخرون
منشور في: (2022-12-01)

Myelodysplastic syndrome: classification and prognostic systems
حسب: Rosangela Invernizzi, وآخرون
منشور في: (2011-12-01)

Vaccines: a promising therapy for myelodysplastic syndrome
حسب: Kriti Gera, وآخرون
منشور في: (2024-01-01)

A correlation of ineffective erythropoiesis and dysregulated signaling pathways in myelodysplastic syndromes/neoplasms
حسب: Junying Wu, وآخرون
منشور في: (2025-05-01)

Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms
حسب: Ashikh A. Seethy, وآخرون
منشور في: (2023-10-01)

Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility
حسب: Mohammad Shahjahani, وآخرون
منشور في: (2019-02-01)

Efficacy and safety of decitabine combined with arsenic trioxide in elderly high-risk myelodysplastic neoplasm patients: a retrospective study
حسب: Jianzhong Yang
منشور في: (2025-12-01)

A potential predictive model based on machine learning and CPD parameters in elderly patients with aplastic anemia and myelodysplastic neoplasms
حسب: Yuxiang Qi, وآخرون
منشور في: (2024-12-01)

Treatment of Vietnamese patients diagnosed with myelodysplastic neoplasms: Practical experience in a developing country
حسب: Quang Hao Nguyen, وآخرون
منشور في: (2025-01-01)

Single-cell transcriptomics dissects the transcriptome alterations of hematopoietic stem cells in myelodysplastic neoplasms
حسب: Xiangzong Zeng, وآخرون
منشور في: (2024-04-01)

Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS)
حسب: Josephine Lucero, وآخرون
منشور في: (2023-06-01)

The Differencies in Adult and Pediatric Myelodysplastic Syndrome: A Review
حسب: Vasekova P, وآخرون
منشور في: (2016-08-01)

Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms
حسب: Zdenek Krejcik, وآخرون
منشور في: (2025-01-01)

ROLE AND TIMING OF HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME
حسب: Teresa L Field, وآخرون
منشور في: (2010-07-01)

Diagnostic and prognostic value of ferroptosis-related genes in patients with Myelodysplastic neoplasms
حسب: Xiaomei Chen, وآخرون
منشور في: (2023-12-01)

The prognostic role of lymphocyte to monocyte ratio (LMR) in patients with Myelodysplastic Neoplasms
حسب: Chuanyang Lu, وآخرون
منشور في: (2023-12-01)

Myelodysplastic Syndrome in a Patient With Cronkhite‐Canada Syndrome
حسب: Kevin G. Shim, وآخرون
منشور في: (2025-08-01)

IRF4 rs12203592 Risk Variant Shows Effect in European But Not Non-European and Admixed Myelodysplastic Syndrome Patients
حسب: Jonas Nogueira Ferreira Maciel Gusmão, وآخرون
منشور في: (2025-03-01)

Myelodysplastic Syndrome: Diagnosis and Screening
حسب: Francisco P. Tria, وآخرون
منشور في: (2022-06-01)

Impaired LTB4-induced neutrophil chemotactic directionality in myelodysplastic neoplasms patients
حسب: Xinyan Xie, وآخرون
منشور في: (2025-12-01)

Myelodysplastic syndrome with synchronous gastric cancer: when the symptoms suggest something else
حسب: Paula de Melo Campos, وآخرون
منشور في: (2014-12-01)

Predictors of vascular disease in myelodysplastic syndromes
حسب: Mark G. Faber, وآخرون
منشور في: (2020-11-01)

Erythrophagocytosis by neutrophils and megakaryocytic emperipolesis are distinctive morphologic features in del(20q)-associated myelodysplastic syndrome
حسب: Min Shi, MD, PhD, وآخرون
منشور في: (2017-06-01)